-
481
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
Published 2025-01-01“…Abstract Dendritic cells (DC) are key players in antitumor immune responses. Tumors exploit their plasticity to escape immune control; their aberrant surface carbohydrate patterns (e.g., glycans) shape immune responses through lectin binding, and manipulate the metabolism of immune cells, including DCs to alter their function and escape immune surveillance. …”
Get full text
Article -
482
BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
Published 2025-02-01“…Administered at birth, BCG induces broad immune responses against a large number of antigens shared with Mycobacterium tuberculosis (Mtb), but protection wanes over time. …”
Get full text
Article -
483
Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens
Published 2025-02-01“…ABSTRACT Bacterial infections can induce exuberant immune responses that can damage host tissues. Previously, we demonstrated that systemic Escherichia coli infection in mice causes tissue damage in the liver. …”
Get full text
Article -
484
Evaluation of the Expression of Infection-Related Long Noncoding RNAs among COVID-19 Patients: A Case-Control Study
Published 2024-01-01“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a worldwide pandemic, activates signaling cascades and leads to innate immune responses and secretion of multiple chemokines and cytokines. …”
Get full text
Article -
485
Safety, Tolerability, and Immunogenicity of the Invaplex<sub>AR-Detox</sub> <i>Shigella</i> Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protoc...
Published 2025-01-01“…The adjuvant dmLT has been shown to enhance Shigella immune responses in mice, has safely been administered intramuscularly, and was shown to enhance immune responses in healthy volunteers when given in combination with other antigens in phase I trials. …”
Get full text
Article -
486
Immune Evasion Strategies of Pre-Erythrocytic Malaria Parasites
Published 2014-01-01“…Although the robust host immune responses limit the development of the liver stage, malaria parasites have also evolved strategies to suppress host defenses at the pre-erythrocytic stage. …”
Get full text
Article -
487
Insights into the Roles of B Cells in Patients with Sepsis
Published 2023-01-01“…Sepsis-related deaths primarily occur during immunosuppression; the disease can hamper the numbers and function of B cells, which mediate innate and adaptive immune responses to maintain immune homeostasis. Dysfunction of B cells, along with aggravated immunosuppression, are closely related to poor prognosis. …”
Get full text
Article -
488
Neutrophil Reverse Migration Becomes Transparent with Zebrafish
Published 2012-01-01“…Still, the mechanisms underlying neutrophil reverse migration and its effects on the resolution or priming of immune responses remain unclear. Here, we review the current knowledge of neutrophil reverse migration, its potential roles in host immunity, and the live imaging tools that make zebrafish a valuable model for increasing our knowledge of neutrophil behavior in vivo.…”
Get full text
Article -
489
Microbiota modifications in prehabilitation – the next step towards comprehensive preparation for surgery. The scoping review
Published 2024-12-01“…Evidence from systematic reviews, meta-analyses, and randomised controlled trials suggests that microbiota-targeted interventions can reduce SSIs, enhance immune responses, and promote quicker recovery. The review advocates for an individualised approach to prehabilitation, incorporating microbiota modifications based on patient-specific factors and surgery type. …”
Get full text
Article -
490
Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
Published 2025-01-01“…It facilitates the clearance of damaged hepatocytes, preventing secondary injury, and triggers immune responses to eliminate pathogens and damaged cells. …”
Get full text
Article -
491
Pathogenicity, Host Responses and Implications for Management of Enterohemorrhagic Escherichia coli O157:H7 Infection
Published 2013-01-01“…The present review focuses on the history, epidemiology and evolution of the pathogen; provides a mechanistic overview of major virulence factors (including Shiga toxins, locus of enterocyte effacement pathogenicity island and pO157 plasmid); discusses host immune responses to infection; considers available animal models; and provides an overview of current and potential future management considerations.…”
Get full text
Article -
492
Medicinal products used for the treatment and prophylaxis of COVID-19
Published 2020-06-01“…The article summarizes the known data on the efficacy and safety of antiviral agents and medicines used to control immune responses, precautions and possible adverse effects on the nervous system, which could be beneficial to the physicians in clinical practice. …”
Get full text
Article -
493
Regulation of Immune Cell Functions by Metabolic Reprogramming
Published 2018-01-01“…Recent findings show that the metabolic status of immune cells can determine immune responses. Metabolic reprogramming between aerobic glycolysis and oxidative phosphorylation, previously speculated as exclusively observable in cancer cells, exists in various types of immune and stromal cells in many different pathological conditions other than cancer. …”
Get full text
Article -
494
Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
Published 2012-01-01“…There is an opportunity to harness these immune responses in the design of more effective HIV vaccines.…”
Get full text
Article -
495
Dynamics of stochastic mutation to immunodominance
Published 2012-09-01“…Although a virus contains several epitopes that can be recognized by cytotoxic T lymphocytes (CTL), the immune responses against different epitopes are not uniform. …”
Get full text
Article -
496
Pulmonary granuloma formation during latent Cryptococcus neoformans infection in C3HeB/FeJ mice involves progression through three immunological phases
Published 2025-02-01“…Immunocompetent host immune responses, such as formation of pulmonary granulomas, control the infection and prevent disseminated disease. …”
Get full text
Article -
497
A novel platform for engineered AAV-based vaccines
Published 2025-03-01“…Moreover, the AAV.RBDs were able to trigger RBD-specific cellular immune responses in peripheral human lymphocytes. In conclusion, this novel AAV-based next-generation vaccine platform allows for the presentation of large antigenic sequences to elicit strong and specific immune responses. …”
Get full text
Article -
498
Effectivity of prebiotic mannan oligosaccharides as the immunity enhancer and growth response on whiteleg shrimp Litopenaeus vannamei against white spot disease
Published 2018-05-01“…ABSTRACT This study aimed to evaluate the immune response and growth performance of white shrimp administered with prebiotic mannan oligosaccharides (MOS) with dosages of (0%, 0.2%, 0.4%, and 0.8% in diet) and used in the feeding trial. …”
Get full text
Article -
499
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
Published 2025-12-01“…All 1- and 2-dose Ad26.COV2.S primary schedules elicited robust peak Spike-binding antibody responses and virus neutralizing titers against the reference strain, in participants with and without preexisting SARS-CoV-2 immunity. Immune responses were durable for at least 6 months. Spike-binding antibody responses were comparable to those elicited in young adults aged 18–25 years who received a standard dose of Ad26.COV2.S in Phase 3 efficacy studies Reduced doses/dose volume of Ad26.COV2.S had an acceptable safety profile and elicited robust humoral immune responses in adolescents aged 12–17 years. …”
Get full text
Article -
500
Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
Published 2025-01-01“…Further clinical studies are necessary to validate the therapeutic potential of these anti-inflammatory drugs in enhancing immune responses in pancreatic cancer.…”
Get full text
Article